|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Centient Investor Release: Biggest Biotech Winners And Losers During Q3
10/19/2005 5:11:49 PM
During the third quarter of 2004, only one company posted gains in excess of 100%: NitroMed (NTMD) with a spectacular rise of 291% during the three-month period. The other big gainers for the quarter were Rigel (RIGL) at 78%, AtheroGenix (AGIX) at 73% and Avanir (AVN) at 69%. Third Wave (TWTI) and Caliper (CALP) each gained slightly more than 50%.
The biggest losers in Q3 were Maxim (MAXM) at 71% and Valentis (VLTS) at 62%. Exact (EXAS), Ciphergen (CIPH), and Immunomedics (IMMU) follow, all at a 47% loss. Nanogen (NGEN), Genetronics (GEB), Ligand (LGND) and Novavax (NVAX) each dropped around 45% of their value.
|
|
|
|
|
|
|
• Caliper Life Sciences, Inc. (Formerly Zymark Corporation)
|
|
• EXACT Sciences Corporation
|
|
• Genetronics, Inc.
|
|
• Immunomedics, Inc.
|
|
• Rigel Pharmaceuticals, Inc.
|
|
• Third Wave Technologies, Inc.
|
|
• Nanogen, Inc.
|
|
• NitroMed, Inc.
|
|
• AtheroGenics, Inc.
|
|
• ChinaBio Today
|
|
• Ciphergen Biosystems, Inc.
|
|
• Novavax, Inc.
|
|
• Valentis, Inc.
|
|
• Ligand Pharmaceuticals Inc.
|
|
• AVANIR Pharmaceuticals
|
|
• Maxim Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|